Gateway Investment Advisers LLC Sells 2,783 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gateway Investment Advisers LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 109,554 shares of the medical equipment provider’s stock after selling 2,783 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Intuitive Surgical were worth $57,183,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter valued at about $33,000. Mark Sheptoff Financial Planning LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at about $37,000. Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. Finally, DT Investment Partners LLC increased its stake in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 0.9 %

Intuitive Surgical stock traded down $5.37 during trading hours on Thursday, hitting $574.74. The stock had a trading volume of 182,925 shares, compared to its average volume of 1,457,040. The stock’s 50-day moving average price is $537.05 and its 200-day moving average price is $496.50. Intuitive Surgical, Inc. has a 12-month low of $355.17 and a 12-month high of $585.50. The stock has a market capitalization of $204.71 billion, a P/E ratio of 92.40, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Truist Financial raised their target price on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.